They can be if it goes with getting filings upto date, potential uplisting to higher exchange and to attrack institutional investors. All which is very important for Biotechs and Medical device companies that wants financing to finance important R&D and go to market of approved products. PMDI is on the cusp of going from a R&D company to operational. This makes them a prime candidate for a acquisition. If we get partner news with a BIG pharma company then this could REALLY blow.
Market Data 
Markets 
AI
